EIR Ventures
Investor profile
Venture capital
EIR Ventures has backed 5 European tech companies across 5 funding rounds between 2020 and 2022, joining rounds totalling €77M. Most active in Healthtech. Data as of Nov 2026.
Deals
5
distinct rounds
Companies
5
backed
Active span
2020–2022
3 yrs
Total round €
€77M
sum of rounds joined
Deals by year
distinct rounds / yearEIR Ventures — deals by year — interactive chart.
Data table
| EIR Ventures — deals by year | |
|---|---|
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 3 |
Top sectors
by dealsEIR Ventures — top sectors — interactive chart.
Data table
| EIR Ventures — top sectors | |
|---|---|
| Healthtech | 5 |
Stages
by dealsEIR Ventures — stages — interactive chart.
Data table
| EIR Ventures — stages | |
|---|---|
| Other | 3 |
| Seed | 1 |
| Series A | 1 |
Countries
by dealsEIR Ventures — countries — interactive chart.
Data table
| EIR Ventures — countries | |
|---|---|
| Denmark | 3 |
| Netherlands | 1 |
| Sweden | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Cinclus Pharma | Sweden | 1 | €48M |
| Scenic Biotech | Netherlands | 1 | €28M |
| Henlez | Denmark | 1 | €1.0M |
| Synklino | Denmark | 1 | €0 |
| ISD Immunotech | Denmark | 1 | €0 |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Cinclus Pharma | Other | €48M | 2022-05 |
| Scenic Biotech | Series A | €28M | 2022-03 |
| Henlez | Seed | €1.0M | 2022-10 |
| Synklino | Other | — | 2020-10 |